Olcay Tatar

1.6k total citations
37 papers, 1.3k citations indexed

About

Olcay Tatar is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Olcay Tatar has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Ophthalmology, 20 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Olcay Tatar's work include Retinal Diseases and Treatments (25 papers), Glaucoma and retinal disorders (14 papers) and Retinal and Optic Conditions (9 papers). Olcay Tatar is often cited by papers focused on Retinal Diseases and Treatments (25 papers), Glaucoma and retinal disorders (14 papers) and Retinal and Optic Conditions (9 papers). Olcay Tatar collaborates with scholars based in Germany, Japan and Belgium. Olcay Tatar's co-authors include Salvatore Grisanti, Karl Ulrich Bartz‐Schmidt, Peter Szurman, Focke Ziemssen, Efdal Yoeruek, Sigrid Henke‐Fahle, Sabine Aisenbrey, S. Biester, Swaantje Peters and Kei Shinoda and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Progress in Retinal and Eye Research.

In The Last Decade

Olcay Tatar

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olcay Tatar Germany 18 1.0k 752 280 149 53 37 1.3k
Emanuela Aragona Italy 21 827 0.8× 583 0.8× 320 1.1× 138 0.9× 26 0.5× 93 1.2k
André Rosentreter Germany 21 913 0.9× 811 1.1× 103 0.4× 138 0.9× 96 1.8× 64 1.2k
Jan C. van Meurs Netherlands 21 1.1k 1.1× 664 0.9× 359 1.3× 148 1.0× 14 0.3× 43 1.4k
John W. Cowden United States 19 563 0.5× 820 1.1× 176 0.6× 216 1.4× 74 1.4× 36 1.1k
Tae-Young Chung South Korea 19 532 0.5× 556 0.7× 130 0.5× 171 1.1× 23 0.4× 50 835
Aparna Ramasubramanian United States 16 557 0.5× 279 0.4× 104 0.4× 195 1.3× 21 0.4× 75 781
Claudia S. Alge Germany 17 654 0.6× 437 0.6× 413 1.5× 26 0.2× 64 1.2× 31 1.0k
John Christoforidis United States 17 735 0.7× 560 0.7× 250 0.9× 38 0.3× 18 0.3× 43 939
Jonathan Clarke United Kingdom 13 533 0.5× 349 0.5× 431 1.5× 117 0.8× 38 0.7× 34 1.0k
Kayo Nishi Japan 29 2.1k 2.1× 1.4k 1.8× 326 1.2× 203 1.4× 37 0.7× 54 2.3k

Countries citing papers authored by Olcay Tatar

Since Specialization
Citations

This map shows the geographic impact of Olcay Tatar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olcay Tatar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olcay Tatar more than expected).

Fields of papers citing papers by Olcay Tatar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olcay Tatar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olcay Tatar. The network helps show where Olcay Tatar may publish in the future.

Co-authorship network of co-authors of Olcay Tatar

This figure shows the co-authorship network connecting the top 25 collaborators of Olcay Tatar. A scholar is included among the top collaborators of Olcay Tatar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olcay Tatar. Olcay Tatar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grisanti, Swaantje, et al.. (2014). DIFFERENTIAL EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A ISOFORMS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 35(4). 764–772. 15 indexed citations
2.
Sobolewska, Bianka, et al.. (2014). Long-Term Visual Outcome and Its Predictive Factors Following Treatment of Acute Submacular Hemorrhage with Intravitreous Injection of Tissue Plasminogen Factor and Gas. Journal of Ocular Pharmacology and Therapeutics. 30(7). 567–572. 11 indexed citations
3.
Yoeruek, Efdal, Olcay Tatar, Martin S. Spitzer, et al.. (2010). Effects of Bevacizumab on Apoptosis, Na<sup>+</sup>-K<sup>+</sup>-Adenosine Triphosphatase and Zonula Occludens 1 Expression on Cultured Corneal Endothelial Cells. Ophthalmic Research. 44(1). 43–49. 6 indexed citations
4.
Lüke, Julia, et al.. (2010). Papillary capillary activation in Terson syndrome. International Ophthalmology. 30(4). 439–441. 1 indexed citations
5.
Grisanti, Salvatore & Olcay Tatar. (2008). The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration. Progress in Retinal and Eye Research. 27(4). 372–390. 139 indexed citations
6.
Yoeruek, Efdal, Martin S. Spitzer, Oğuzhan Saygılı, et al.. (2008). Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use. Journal of Cataract & Refractive Surgery. 34(12). 2139–2145. 64 indexed citations
7.
Tatar, Olcay, Kei Shinoda, E. Kaiserling, et al.. (2008). Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation. British Journal of Ophthalmology. 93(2). 159–165. 4 indexed citations
8.
Zhu, Qi, Focke Ziemssen, Sigrid Henke‐Fahle, et al.. (2008). Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization. Ophthalmology. 115(10). 1750–1755.e1. 141 indexed citations
9.
Yoeruek, Efdal, Martin S. Spitzer, Olcay Tatar, et al.. (2007). Safety Profile of Bevacizumab on Cultured Human Corneal Cells. Cornea. 26(8). 977–982. 88 indexed citations
10.
Tatar, Olcay, A. Adam, Kei Shinoda, et al.. (2007). INFLUENCE OF VERTEPORFIN PHOTODYNAMIC THERAPY ON INFLAMMATION IN HUMAN CHOROIDAL NEOVASCULAR MEMBRANES SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina. 27(6). 713–723. 28 indexed citations
11.
Shinoda, Kei, Robert Ręjdak, Frank Schuettauf, et al.. (2007). Early electroretinographic features of streptozotocin‐induced diabetic retinopathy. Clinical and Experimental Ophthalmology. 35(9). 847–854. 44 indexed citations
12.
Ziemssen, Focke, Matthias Lüke, André Messias, et al.. (2007). Safety monitoring in bevacizumab (Avastin) treatment: retinal function assessed by psychophysical (visual fields, colour vision) and electrophysiological (ERG/EOG) tests in two subgroups of patients. International Ophthalmology. 28(2). 101–109. 33 indexed citations
13.
Yoeruek, Efdal, Focke Ziemssen, Sigrid Henke‐Fahle, et al.. (2007). Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Acta Ophthalmologica. 86(3). 322–328. 150 indexed citations
14.
Grisanti, Salvatore, et al.. (2006). Intraocular Bevacizumab (Avastin): for Rubeosis Iridis. Investigative Ophthalmology & Visual Science. 47(13). 5219–5219. 1 indexed citations
15.
Tatar, Olcay, Kei Shinoda, A. Adam, et al.. (2006). Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes. British Journal of Ophthalmology. 91(2). 166–173. 28 indexed citations
16.
Tatar, Olcay. (2006). Consequences of Verteporfin Photodynamic Therapy on Choroidal Neovascular Membranes. Archives of Ophthalmology. 124(6). 815–815. 32 indexed citations
17.
Tatar, Olcay, A. Adam, Kei Shinoda, et al.. (2006). Expression of VEGF and PEDF in Choroidal Neovascular Membranes Following Verteporfin Photodynamic Therapy. American Journal of Ophthalmology. 142(1). 95–104.e1. 83 indexed citations
18.
Grisanti, Salvatore, S. Biester, Swaantje Peters, et al.. (2006). Intracameral Bevacizumab for Iris Rubeosis. American Journal of Ophthalmology. 142(1). 158–160. 146 indexed citations
19.
Tatar, Olcay, Salvatore Grisanti, Faik Gelişken, et al.. (2004). Immunohistopathologic Evaluation Of Choroidal Neovascular Membranes Following Verteporfin–photodynamic Therapy. Investigative Ophthalmology & Visual Science. 45(13). 1781–1781. 1 indexed citations
20.
Grisanti, Salvatore, Olcay Tatar, B. A. Lafaut, et al.. (2004). Immunohistopathologic evaluation of choroidal neovascular membranes following Verteporfin-photodynamic therapy. American Journal of Ophthalmology. 137(5). 914–923. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emanuela Aragona Breakdown of academic impact, for papers by André Rosentreter Breakdown of academic impact, for papers by Jan C. van Meurs Breakdown of academic impact, for papers by John W. Cowden Breakdown of academic impact, for papers by Tae-Young Chung Breakdown of academic impact, for papers by Aparna Ramasubramanian Breakdown of academic impact, for papers by Claudia S. Alge Breakdown of academic impact, for papers by John Christoforidis Breakdown of academic impact, for papers by Jonathan Clarke Breakdown of academic impact, for papers by Kayo Nishi
Rankless by CCL
2026